• Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

DOCUMENTI SIBIOC - SIBioC Documents

Volume:

Biochimica Clinica 2014; 38(1) 39-46

Pubblicato on-line:

DOI:

Scarica in PDF:
Autenticazione richiesta

Identificazione e ruolo dell’esperto in emostasi e trombosi nel Sistema Sanitario Nazionale

AUTORI

Francesco Rodeghiero1, Massimo Morfini2, Carlo Nozzoli3, Cesare Manotti4, Francesco Violi5, Giuseppe Castaldo6, Fabrizio Pane7, Bruno Biasioli8, Claudio Velati9
1Dipartimento di Terapie Cellulari ed Ematologia, Ospedale San Bortolo, Vicenza
2Agenzia per l’Emofilia e Centro di Riferimento Regionale per i Disordini Ereditari del Sanguinamento e 3Dipartimento Area Medica, Azienda Ospedaliero-Universitaria Careggi, Firenze
4Centro per la Trombosi - Centro per le Malattie dell’Emostasi e Cura dell’Emofilia, Azienda Unità Sanitaria Locale, Parma
5Divisione di Medicina Interna C, Università Sapienza, Policlinico Umberto I, Roma
6Dipartimento di Biochimica Clinica e Biotecnologie Mediche, Università di Napoli Federico II
7U.O. Ematologia e Trapianti di Midollo, Azienda Ospedaliera Universitaria Federico II, Napoli
8Ospedale Maggiore - Azienda Ospedaliero Universitaria "Ospedali Riuniti”, Trieste
9Servizio di Immunoematologia e Medicina Trasfusionale, Azienda Ospedaliera Valtellina e Valchiavenna

ABSTRACT

Identification and role of the hemostasis and thrombosis expert in the National Health System

Hemorrhagic and thrombotic diseases are very heterogeneous disorders that may affect a relevant part of the population, as in the case of patients taking antithrombotic drugs. The appropriate management of such conditions requires the availability of specific laboratory assays, together with the knowledge of possible clinical syndromes and of their appropriate treatments. This can be achieved only through second level specialized laboratories supervised by trained personnel. This type of diagnostic and therapeutic organization is not widely available in Italy, but it is present in a limited number of major hospitals, having a nationwide excellence. Increasing the availability of such resources would be very relevant for patients and this effort could also be cost-effective for the National Health System. This document, promoted by the Società Italiana per lo Studio dell’Emostasi e della Trombosi and by other major national scientific societies involved in the field is aimed at identifying the level of scientific and professional career required to define a physician as hemostasis and thrombosis expert, graded for the skills required in different clinical settings.

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967